Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Clinical characteristics and prognostic factors of plasmablastic lymphoma...

Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France

Clinical characteristics and prognostic factors of plasmablastic lymphoma patients ( Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France )

Blinatumomab improves survival of relapsed B-cell leukaemia

Prof Max Topp - University of Würzburg, Würzburg, Germany

Blinatumomab improves survival of relapsed B-cell leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )

Decoding the risk of thromboembolic events in lymphoma patients

Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade...

Decoding the risk of thromboembolic events in lymphoma patients ( Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade, Serbia )

Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia

Dr Charles De Bock - KU Leuven, Leuven, Belgium

Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia ( Dr Charles De Bock - KU Leuven, Leuven, Belgium )

SL401 in patients with rare neoplasm

Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center...

SL401 in patients with rare neoplasm ( Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States )

RNA regulation of JAK-STAT pathways in CML

Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA

RNA regulation of JAK-STAT pathways in CML ( Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA )

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence

Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence ( Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany )

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )

Ten years of letrozole improves survival and quality of life in early-diagnosed...

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )

Daratumumab slows progression in refractory multiple myeloma

Prof Palumbo - University of Turin, Turin, Italy

$Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )$

Developments in haematological malignancies

Dr Stephen Nimer - University of Miami, Miami, USA

Developments in haematological malignancies ( Dr Stephen Nimer - University of Miami, Miami, USA )

Recent developments in targeted therapies

Dr Stephen Nimer - University of Miami, Miami, USA

Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )

More from ecancer